ArticleClinical and molecular allergy : CMA2015

Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA - an observational, 2 phase, patient reported outcomes study.

Giorgio Walter Canonica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.